GALECTIN THERAPEUTICS INC. Deferred Tax Assets, Operating Loss Carryforwards
GALECTIN THERAPEUTICS INC. (GALT) had Deferred Tax Assets, Operating Loss Carryforwards of $69.30 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $69.30M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $63.06M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $61.43M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $53.12M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $69.30M 10-K · filed 2026-03-31 |
| 2024-12-31 | $63.06M 10-K · filed 2026-03-31 |
| 2023-12-31 | $61.43M 10-K · filed 2025-03-31 |
| 2022-12-31 | $53.12M 10-K · filed 2024-03-29 |
| 2021-12-31 | $54.95M 10-K · filed 2023-03-30 |
| 2020-12-31 | $46.20M 10-K · filed 2022-03-31 |
| 2019-12-31 | $39.98M 10-K · filed 2021-03-31 |
| 2018-12-31 | $36.42M 10-K · filed 2020-03-16 |
| 2017-12-31 | $34.17M 10-K · filed 2019-03-06 |
| 2016-12-31 | $44.22M 10-K · filed 2018-03-29 |
| 2015-12-31 | $37.15M 10-K · filed 2017-03-28 |
| 2014-12-31 | $30.58M 10-K · filed 2016-03-15 |
| 2013-12-31 | $25.88M 10-K · filed 2015-03-18 |
| 2012-12-31 | $21.75M 10-K · filed 2014-03-21 |
| 2011-12-31 | $19.12M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |